Summary
Cartesian Therapeutics
Founded in 2016
Description
Cartesian Therapeutics is a fully integrated, clinical stage biopharmaceutical company developing novel cell and gene immunotherapies to treat cancer and autoimmune diseases.
Strengths
- Revenue growth is more steady than the industry average
- Since Cartesian Therapeutics was founded, the company has grown faster than the industry average
Weaknesses
- Cartesian Therapeutics has a very small market share in their industry
- Revenue generated per employee is less than the industry average
- Revenue growth is less than the industry average
- The number of employees is not growing as fast as the industry average
Annual Revenue
Cartesian Therapeutics's annual revenue
$4185000
Based on Kona Equity data
-
Revenue per employee
$279000
-
Variance of revenue growth
0.01
-
Annual revenue growth since founding
$523125
-
Revenue growth rate from first known quarter to current
-26.1%
Employee Count
15 employees
-
Employee growth rate from first known quarter to current
-23.1%
Executives
Albina Benson
Director, Gmp Manufacturing
a**@cartesiantherapeutics.comMinhtran Casi
Director, Research
m**@cartesiantherapeutics.comMilos Miljkovic
Chief Medical Officer
m**@cartesiantherapeutics.comHafsa Kamboh
Director, Translational Medicine
h**@cartesiantherapeutics.comMichael Singer
Chief Scientific Officer
m**@cartesiantherapeutics.comMetin Kurtoglu
Chief Medical Officer
m**@cartesiantherapeutics.comEmily English
Director, Quality
e**@cartesiantherapeutics.comMurat Kalayoglu
President & Chief Executive Officer
m**@cartesiantherapeutics.comPhone Therapeutics
President & Chief Executive Officer
p**@cartesiantherapeutics.comHeng Xu
Research Associate & Scientist
h**@cartesiantherapeutics.comG Score - 2
The G Score is an eight-point scale where firms are given a score of 1 for each of the criteria that they pass. The G score compares a company against the industry median to find those that are healthy and growing.
- G5 Variance of revenue growth is less than the industry average
- G6 Annual revenue growth since founding is higher than the industry average.
Location
Unlock unlimited leads
Similar Companies
Key Information
- Name: Cartesian Therapeutics
- Category: Pharmaceuticals
- Industry: Biotechnology Company
- SIC: 80; 283
- NAICS: 541; 5417
See similar companies
-
By City Gaithersburg Small Biotechnology Company in Gaithersburg Mid-size Biotechnology Company in Gaithersburg Pharmaceuticals in Gaithersburg Small Pharmaceuticals in Gaithersburg Mid-size Pharmaceuticals in Gaithersburg
-
By State MD Small companies in MD Pharmaceuticals in MD Small Pharmaceuticals in MD Mid-size Pharmaceuticals in MD Small Biotechnology Company in MD Mid-size Biotechnology Company in MD
-
By Category Pharmaceuticals Small Pharmaceuticals Mid-size Pharmaceuticals
-
By Industry Biotechnology Company Small Biotechnology Company Mid-size Biotechnology Company Pharmaceuticals and Biotechnology Company
-
Firmographic data G Score of 2 Founded in 2016 SIC: 80 SIC: 283 NAICS: 541 NAICS: 5417 #Biotechnology #Pharmaceuticals #Healthcare
Frequently Asked Questions
Cartesian Therapeutics's headquarters are located at 704 Quince Orchard Rd Gaithersburg, MD 20878.
Cartesian Therapeutics's official website is cartesiantherapeutics.com
Cartesian Therapeutics's annual revenue is $4.2 M.
Cartesian Therapeutics's SIC: 80; 283
Cartesian Therapeutics's NAICS: 541; 5417.
Cartesian Therapeutics has 15 employees
Cartesian Therapeutics is in the industry of Pharmaceuticals.